INM
Price
$2.91
Change
-$0.14 (-4.59%)
Updated
Jul 3 closing price
Capitalization
9.19M
PULM
Price
$6.53
Change
-$0.47 (-6.71%)
Updated
Jul 3 closing price
Capitalization
23.85M
32 days until earnings call
Interact to see
Advertisement

INM vs PULM

Header iconINM vs PULM Comparison
Open Charts INM vs PULMBanner chart's image
InMed Pharmaceuticals
Price$2.91
Change-$0.14 (-4.59%)
Volume$56.88K
Capitalization9.19M
Pulmatrix
Price$6.53
Change-$0.47 (-6.71%)
Volume$15.7K
Capitalization23.85M
INM vs PULM Comparison Chart in %
Loading...
INM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PULM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INM vs. PULM commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INM is a StrongBuy and PULM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (INM: $2.91 vs. PULM: $6.53)
Brand notoriety: INM and PULM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INM: 1% vs. PULM: 41%
Market capitalization -- INM: $9.19M vs. PULM: $23.85M
INM [@Biotechnology] is valued at $9.19M. PULM’s [@Biotechnology] market capitalization is $23.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INM’s FA Score shows that 0 FA rating(s) are green whilePULM’s FA Score has 0 green FA rating(s).

  • INM’s FA Score: 0 green, 5 red.
  • PULM’s FA Score: 0 green, 5 red.
According to our system of comparison, PULM is a better buy in the long-term than INM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INM’s TA Score shows that 5 TA indicator(s) are bullish while PULM’s TA Score has 3 bullish TA indicator(s).

  • INM’s TA Score: 5 bullish, 4 bearish.
  • PULM’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, INM is a better buy in the short-term than PULM.

Price Growth

INM (@Biotechnology) experienced а -15.90% price change this week, while PULM (@Biotechnology) price change was -6.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

INM is expected to report earnings on May 12, 2025.

PULM is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PULM($23.8M) has a higher market cap than INM($9.19M). PULM YTD gains are higher at: -6.447 vs. INM (-36.601). INM has higher annual earnings (EBITDA): -7.86M vs. PULM (-9.58M). PULM has more cash in the bank: 7.71M vs. INM (4.68M). PULM has less debt than INM: PULM (0) vs INM (849K). INM has higher revenues than PULM: INM (4.92M) vs PULM (1.92M).
INMPULMINM / PULM
Capitalization9.19M23.8M39%
EBITDA-7.86M-9.58M82%
Gain YTD-36.601-6.447568%
P/E Ratio0.01N/A-
Revenue4.92M1.92M256%
Total Cash4.68M7.71M61%
Total Debt849K0-
FUNDAMENTALS RATINGS
INM vs PULM: Fundamental Ratings
INM
PULM
OUTLOOK RATING
1..100
9850
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
40
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
6243
P/E GROWTH RATING
1..100
84100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PULM's Valuation (40) in the Biotechnology industry is in the same range as INM (42) in the null industry. This means that PULM’s stock grew similarly to INM’s over the last 12 months.

PULM's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as INM (100) in the null industry. This means that PULM’s stock grew similarly to INM’s over the last 12 months.

PULM's SMR Rating (98) in the Biotechnology industry is in the same range as INM (98) in the null industry. This means that PULM’s stock grew similarly to INM’s over the last 12 months.

PULM's Price Growth Rating (43) in the Biotechnology industry is in the same range as INM (62) in the null industry. This means that PULM’s stock grew similarly to INM’s over the last 12 months.

INM's P/E Growth Rating (84) in the null industry is in the same range as PULM (100) in the Biotechnology industry. This means that INM’s stock grew similarly to PULM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INMPULM
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
N/A
Bullish Trend 8 days ago
70%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
INM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PULM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PKX57.002.60
+4.78%
POSCO Holdings
BRY3.100.04
+1.31%
Berry Corp
APPN30.480.34
+1.13%
Appian Corp
HCWB4.06-0.11
-2.64%
HCW Biologics Inc
MSPR1.02-0.06
-5.56%
MSP Recovery Inc

INM and

Correlation & Price change

A.I.dvisor indicates that over the last year, INM has been loosely correlated with TTNP. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if INM jumps, then TTNP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INM
1D Price
Change %
INM100%
-4.59%
TTNP - INM
44%
Loosely correlated
+1.15%
EYEN - INM
39%
Loosely correlated
N/A
OMER - INM
36%
Loosely correlated
+3.56%
VTYX - INM
31%
Poorly correlated
+2.97%
PULM - INM
30%
Poorly correlated
-6.71%
More

PULM and

Correlation & Price change

A.I.dvisor indicates that over the last year, PULM has been loosely correlated with ORMP. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if PULM jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PULM
1D Price
Change %
PULM100%
-6.71%
ORMP - PULM
33%
Loosely correlated
+0.93%
INM - PULM
30%
Poorly correlated
-4.59%
GERN - PULM
27%
Poorly correlated
+2.14%
TSHA - PULM
26%
Poorly correlated
+0.82%
PMVP - PULM
25%
Poorly correlated
+8.18%
More